Announcements Trials
Browse Landscape

Phase

Phase NA 18Phase 4 3Phase 2 3Phase 3 2Phase EARLY_PHASE1 1Phase 2/3 1Phase 1 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 3

Sponsor

Conditions

Polycystic Ovary Syndrome 3Insulin Resistance 2Periodontitis 1Hyperandrogenism 1Glucose Intolerance 1Anovulation 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 649Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Inositol × Clear all
NCT03864068 2026-01-07

INSUPP-PCOS

Milton S. Hershey Medical Center

Phase 2 Completed
154 enrolled

Anovulation, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism, Glucose Intolerance

NCT04867252 2021-09-13

Effects of Combined Resveratrol and Myo-inositol on Altered Metabolic, Endocrine Parameters and Perceived Stress in Patients With Polycystic Ovarian Syndrome

Khyber Medical University Peshawar

Phase 2 Completed
88 enrolled

Polycystic Ovary Syndrome

NCT02633462 2015-12-17

Non-surgical Periodontal Therapy and Myo-inositol in Polycystic Ovary Syndrome Women Having Chronic Periodontitis

Postgraduate Institute of Dental Sciences Rohtak

Phase 2 Unknown
56 enrolled

Insulin Resistance, Periodontitis, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡